人结肠类器官染色体工程构建传统锯齿状腺瘤模型
研究利用CRISPR-Cas9对人结肠类器官进行染色体工程,引入R-spondin基因融合、BRAF V600E突变、TP53破坏及GREM1过表达,并移植至NOG小鼠结肠,发现BRAF V600E联合R-spondin融合形成平坦锯齿状病变,额外GREM1过表达则形成组织学类似传统锯齿状腺瘤(TSA)的息肉样肿瘤。
要点
- 染色体工程需破坏TP53或培养于含IGF1和FGF2的培养基。
- BRAF V600E联合R-spondin融合在鼠结肠形成平坦锯齿状病变。
- GREM1过表达叠加上述改变可形成组织学类似TSA的息肉样肿瘤。
核心结论
- 成功实现人正常结肠类器官的染色体工程,所构建模型可模拟人TSA的组织病理学特征。
研究设计与样本
- 研究利用CRISPR-Cas9对人结肠类器官进行染色体和遗传修饰,并移植至NOG小鼠结肠观察肿瘤生长。
- 研究建立了2例患者来源的TSA类器官系,并表征其遗传特征和表型。
主要发现
- 表达BRAF V600E和R-spondin基因融合的类器官在小鼠结肠中形成平坦锯齿状病变。
- 患者来源TSA类器官生长不依赖外源性R-spondin,其中1株不依赖Noggin。
- 过表达GREM1联合BRAF V600E和R-spondin融合的类器官在小鼠中形成组织学类似TSA的息肉样肿瘤。
- 异种移植肿瘤在LGR5表达细胞丢失后仍持续存在。
关键数值与推荐
- 染色体工程需破坏TP53或使用含IGF1和FGF2的培养基。
- 通过双顺反子盒在LGR5基因下游表达二聚化诱导自杀基因和荧光标记,加入二聚化剂可清除LGR5+细胞。
临床怎么用
- 该模型可用于研究携带RSPO融合基因和GREM1过表达的人结直肠肿瘤进展。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Traditional serrated adenomas (TSAs) are rare colorectal polyps with unique histologic features. Fusions in R-spondin genes have been found in TSAs, but it is not clear whether these are sufficient for TSA development, due to the lack of a chromosome engineering platform for human tissues. We studied the effects of fusions in R-spondin genes and other genetic alterations found in TSA using CRISPR-Cas9-mediated chromosome and genetic modification of human colonic organoids. METHODS: We introduced chromosome rearrangements that involve R-spondin genes into human colonic organoids, with or without disruption of TP53, using CRISPR-Cas9 (chromosome-engineered organoids). We then knocked a mutation into BRAF encoding the V600E substitution and overexpressed the GREM1 transgene; the organoids were transplanted into colons of NOG mice and growth of xenograft tumors was measured. Colon tissues were collected and analyzed by immunohistochemistry or in situ hybridization. We also established 2 patient-derived TSA organoid lines and characterized their genetic features and phenotypes. We inserted a bicistronic cassette expressing a dimerizer-inducible suicide gene and fluorescent marker downstream of the LGR5 gene in the chromosome-engineered organoids; addition of the dimerizer eradicates LGR5+ cells. Some tumor-bearing mice were given intraperitoneal injections of the dimerizer to remove LGR5-expressing cells. RESULTS: Chromosome engineering of organoids required disruption of TP53 or culture in medium containing IGF1 and FGF2. In colons of mice, organoids that expressed BRAFV600E and fusions in R-spondin genes formed flat serrated lesions. Patient-derived TSA organoids grew independent of exogenous R-spondin, and 1 line grew independent of Noggin. Organoids that overexpressed GREM1, in addition to BRAFV600E and fusions in R-spondin genes, formed polypoid tumors in mice that had histologic features similar to TSAs. Xenograft tumors persisted after loss of LGR5-expressing cells. CONCLUSIONS: We demonstrated efficient chromosomal engineering of human normal colon organoids. We introduced genetic and chromosome alterations into human colon organoids found in human TSAs; tumors grown from these organoids in mice had histopathology features of TSAs. This model might be used to study progression of human colorectal tumors with RSPO fusion gene and GREM1 overexpression.
引用
- Kawasaki K, Fujii M, Sugimoto S, et al. Chromosome Engineering of Human Colon-Derived Organoids to Develop a Model of Traditional Serrated Adenoma. Gastroenterology. 2019. PMID: 31622618. doi:10.1053/j.gastro.2019.10.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。